Literature DB >> 12657375

Variants of kappa-opioid receptor gene and mRNA in alcohol-preferring and alcohol-avoiding mice.

Mariko Saito1, Marissa A Ehringer, Reka Toth, Melinda Oros, Istvan Szakall, James M Sikela, Csaba Vadasz.   

Abstract

Results of recent studies have indicated an association between voluntary alcohol intake and activities of kappa-opioid receptor systems in animal models. We assessed the possibility that genetic differences observed in alcohol preference among mouse strains are related to possible polymorphisms of the kappa-opioid receptor gene (Oprk1). We compared DNA sequences of the coding region and the promoter/regulatory region of Oprk1 among C57BL/6ByJ (B6, alcohol-preferring), BALB/cJ (alcohol-avoiding), CXBI (alcohol-avoiding), and six B6.C and B6.I Recombinant QTL Introgression (RQI) strains, which carry approximately 3% of the donor BALB/cJ genome in the background B6 genome and showed various alcohol preferences. Although there were no sequence differences in the coding region, BALB/cJ had a single nucleotide polymorphism (SNP) in the promoter region, which was not detected in other strains. The results indicate that the difference in alcohol preference between B6 and BALB/cJ is not correlated with polymorphisms of Oprk1. However, results of further studies comparing Oprk1 mRNA expression between B6 and BALB/cJ showed that Oprk1 expression is regulated differently in these strains. Also, DBA/2J mice (alcohol-avoiding) showed expression of Oprk1 mRNA subtypes (alternatively spliced) different from B6 and BALB/cJ mice. Search of the Celera Genomics database indicated that DBA/2J had several SNP sites in the promoter/regulatory regions, which might explain the different expression of Oprk1 mRNA subtypes in this strain. The strain-dependent variation in the expression of alternatively spliced genes can be a significant source of phenotypic variation of complex traits such as alcohol preference.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657375     DOI: 10.1016/s0741-8329(02)00322-1

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  14 in total

1.  Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains.

Authors:  Csaba Vadasz; Mariko Saito; Beatrix M Gyetvai; Melinda Oros; Istvan Szakall; Krisztina M Kovacs; Vidudala V T S Prasad; Grant Morahan; Reka Toth
Journal:  Neurochem Res       Date:  2007-02-02       Impact factor: 3.996

Review 2.  Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.

Authors:  Elyse M Cornett; Michelle A Carroll Turpin; Allison Pinner; Pankaj Thakur; Tamizh Selvan Gnana Sekaran; Harish Siddaiah; Jasmine Rivas; Anna Yates; G Jason Huang; Anitha Senthil; Narjeet Khurmi; Jenna L Miller; Cain W Stark; Richard D Urman; Alan David Kaye
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

3.  Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc.

Authors:  Shlomit Flaisher-Grinberg; Shawna D Persaud; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

4.  Genetic variance contributes to dopamine and opioid receptor antagonist-induced inhibition of intralipid (fat) intake in inbred and outbred mouse strains.

Authors:  Cheryl T Dym; Veronica S Bae; Tamar Kraft; Yakov Yakubov; Amanda Winn; Anthony Sclafani; Richard J Bodnar
Journal:  Brain Res       Date:  2009-12-22       Impact factor: 3.252

5.  Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.

Authors:  Vadim Yuferov; David Fussell; K Steven LaForge; David A Nielsen; Derek Gordon; Ann Ho; Suzanne M Leal; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenetics       Date:  2004-12

Review 6.  Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders.

Authors:  Stephen J Glatt; Ori S Cohen; Stephen V Faraone; Ming T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-03-22       Impact factor: 3.568

Review 7.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

8.  Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes.

Authors:  Michal Korostynski; Dorota Kaminska-Chowaniec; Marcin Piechota; Ryszard Przewlocki
Journal:  BMC Genomics       Date:  2006-06-13       Impact factor: 3.969

Review 9.  The evolution of vertebrate opioid receptors.

Authors:  Craig W Stevens
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk.

Authors:  K Xu; D Seo; C Hodgkinson; Y Hu; D Goldman; R Sinha
Journal:  Transl Psychiatry       Date:  2013-08-20       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.